Related references
Note: Only part of the references are listed.The Influence of 5-Fluorouracil on Drug Transporters is a Dose-Dependent Effect Mediated by Altered Expression of miRNAs
Sherien M. El-Daly et al.
EGYPTIAN JOURNAL OF CHEMISTRY (2022)
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
Tomonari Suetsugu et al.
ONCOLOGY REPORTS (2021)
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
Chinmayee Sethy et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Dual Kinase Inhibition of EGFR/HER2: Design, Synthesis and Molecular Docking of Thiazolylpyrazolyl-Based Aminoquinoline Derivatives as Anticancer Agents**
Rasha Z. Batran et al.
CHEMISTRYSELECT (2021)
Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
Huan Xiao et al.
FRONTIERS IN PHARMACOLOGY (2021)
IRE1α-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells
Qiang Gao et al.
CANCER LETTERS (2020)
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Ningni Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells
Sherien M. El-Daly et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2020)
Expression of ATP-binding Cassette Transporter 11 (ABCC11) Protein in Colon Cancer
Yasufumi Yamada et al.
ANTICANCER RESEARCH (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
Differential expression of miRNAs regulating NF-κB and STAT3 crosstalk during colitis-associated tumorigenesis
Sherien M. El-Daly et al.
MOLECULAR AND CELLULAR PROBES (2019)
RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways
Tianze Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Over-activation of AKT signaling leading to 5-Fluorouracil resistance in SNU-C5/5-FU cells
Eun-Ji Kim et al.
Oncotarget (2018)
Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines
Gayoung Lee et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone
Cristina Aguirre-Portoles et al.
MOLECULAR ONCOLOGY (2018)
Downregulation of ABC Transporters in Non-neoplastic Tissues Confers Better Prognosis for Pancreatic and Colorectal Cancer Patients
Pavel Dvorak et al.
JOURNAL OF CANCER (2017)
5-Fluorouracil treatment alters the expression of intestinal transporters in rats
Keiichi Yotsumoto et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2017)
Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway
Yun-Xin Lu et al.
CELL DEATH & DISEASE (2016)
ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan
Hoang Dinh Tuy et al.
ONCOLOGY LETTERS (2016)
miRs-134 and-370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
Sherien M. El-Daly et al.
SCIENTIFIC REPORTS (2016)
Portrait of the PI3K/AKT pathway in colorectal cancer
Stine Aske Danielsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Bengt Gustavsson et al.
CLINICAL COLORECTAL CANCER (2015)
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients
Sylvia Chen et al.
PHARMACOGENETICS AND GENOMICS (2015)
Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer
K. Malinowsky et al.
BRITISH JOURNAL OF CANCER (2014)
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
Rodrigo Dienstmann et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Photodynamic therapeutic activity of indocyanine green entrapped in polymeric nanoparticles
Sherien M. El-Daly et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2013)
Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma
Guang Zhang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
PTEN Regulated BCRP/ABCG2 and Side Population Through PI3K/Akt Pathway In Chronic Myeloid Leukemia
Fang-Fang Huang et al.
BLOOD (2013)
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines
Hua Cheng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer
Jianhui Yuan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Exploring the specificity of the PI3K family inhibitor LY294002
Severine I. Gharbi et al.
BIOCHEMICAL JOURNAL (2007)
MRP8/ABCC11 directly confers resistance to 5-fluorouracil
Tetsuya Oguri et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells
Alena Vaculova et al.
FEBS LETTERS (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites
S Pratt et al.
MOLECULAR CANCER THERAPEUTICS (2005)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Share Paper
